-       Report 
   - February 2025
    -  132 Pages 
    Global
   
   From       €3705EUR$4,123USD£3,250GBP 
      €4359EUR$4,850USD£3,823GBP 
                -       Report 
   - February 2025
      Japan, United States, ... Japan, United States, Europe, Global 
   
   From       €3371EUR$3,750USD£2,956GBP 
                  -       Report 
   - February 2025
    -  130 Pages 
    Global
   
   From       €3705EUR$4,123USD£3,250GBP 
      €4359EUR$4,850USD£3,823GBP 
                -       Report 
   - May 2025
    -  200 Pages 
    Europe
   
   From       €2238EUR$2,490USD£1,963GBP 
                -       Report 
   - December 2024
     United States
   
   From       €2247EUR$2,500USD£1,971GBP 
                 -       Report 
   - December 2024
      North America, Mexico, ... North America, Mexico, Canada 
   
   From       €8539EUR$9,500USD£7,488GBP 
                -       Report 
   - February 2025
     Middle East
   
   From       €4045EUR$4,500USD£3,547GBP 
                -       Report 
   - February 2025
      Canada, Mexico, North America Canada, Mexico, North America 
   
   From       €2202EUR$2,450USD£1,931GBP 
                -       Report 
   - February 2025
      Europe, United Kingdom, ... Europe, United Kingdom, Spain, Italy, Germany, France 
   
   From       €2562EUR$2,850USD£2,247GBP 
                -       Report 
   - February 2025
     United States
   
   From       €1303EUR$1,450USD£1,143GBP 
                -       Report 
   - October 2023
    -  157 Pages 
    Global
   
   From       €4179EUR$4,650USD£3,665GBP 
                -       Report 
   - December 2023
    -  111 Pages 
    Global
   
   From       €5348EUR$5,950USD£4,690GBP 
                -       Report 
   - September 2023
    -  180 Pages 
    Global
   
   From       €5348EUR$5,950USD£4,690GBP 
                -       Report 
   - March 2022
    -  300 Pages 
    Global
   
   From       €4494EUR$5,000USD£3,941GBP 
                -       Report 
   - January 2023
    -  50 Pages 
    China
   
   From       €2696EUR$3,000USD£2,365GBP 
                  -       Report 
   - September 2022
    -  112 Pages 
    Global
   
   From       €2840EUR$3,160USD£2,491GBP 
      €3550EUR$3,950USD£3,114GBP 
                -       Report 
   - May 2024
    -  200 Pages 
    Global
   
   From       €3730EUR$4,150USD£3,271GBP 
                  -       Report 
   - August 2024
    -  150 Pages 
    Global
   
   From       €2696EUR$3,000USD£2,365GBP 
      €3371EUR$3,750USD£2,956GBP 
                  -       Report 
   - October 2024
    -  207 Pages 
    Global
   
   From       €5716EUR$6,360USD£5,013GBP 
      €7146EUR$7,950USD£6,267GBP 
                  -       Report 
   - October 2024
    -  237 Pages 
    Global
   
   From       €5716EUR$6,360USD£5,013GBP 
      €7146EUR$7,950USD£6,267GBP 
             
         Heparin is a type of anticoagulant drug used in the treatment of cardiovascular diseases. It is a naturally occurring anticoagulant, derived from the mucous membranes of animals, and is used to prevent the formation of blood clots. It is commonly used in the treatment of deep vein thrombosis, pulmonary embolism, and atrial fibrillation. It is also used to prevent clotting during hemodialysis and to prevent clotting during surgery.
Heparin is available in both injectable and oral forms, and is    typically administered in a hospital setting. It is also available in a variety of formulations, including low molecular weight heparin, unfractionated heparin, and fondaparinux. The cost of heparin varies depending on the formulation and the dosage.
Heparin is a widely used anticoagulant in the cardiovascular drugs market. It is used in a variety of cardiovascular conditions, and is an important part of the treatment of many cardiovascular diseases.
Some companies in the heparin market include Sanofi, Pfizer, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less   Read more